Trials / Completed
CompletedNCT00489346
A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
A Double-Blind, Randomized, Double-Dummy, Multicenter Study to Evaluate and Compare Oral Montelukast and Inhaled Fluticasone in the Control of Asthma for 6- to 14-Year-Olds With Mild Persistent Asthma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 994 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 6 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0476, montelukast sodium / Duration of Treatment: 1 Year | |
| DRUG | Comparator : fluticasone propionate / Duration of Treatment: 1 Year |
Timeline
- Start date
- 2001-10-01
- Primary completion
- 2002-06-01
- Completion
- 2002-06-01
- First posted
- 2007-06-21
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00489346. Inclusion in this directory is not an endorsement.